Interestingly, another gene that belongs to the P13K/mTor pathway involved in inhibiting P13K, namely PTEN, was identified as a periodically mutated tumor suppressor, which confirms previous studies on the recurrent mutation of MEN1 [36]. Here, PTEN is linked to neoplasm.